These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease. Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340 [TBL] [Abstract][Full Text] [Related]
4. Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease. C S; S DK; Ragunathan V; Tiwari P; A S; P BD J Biomol Struct Dyn; 2022 Feb; 40(2):585-611. PubMed ID: 32897178 [TBL] [Abstract][Full Text] [Related]
5. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation. Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783 [TBL] [Abstract][Full Text] [Related]
6. Virtual screening of natural products inspired in-house library to discover potential lead molecules against the SARS-CoV-2 main protease. Garg A; Goel N; Abhinav N; Varma T; Achari A; Bhattacharjee P; Kamal IM; Chakrabarti S; Ravichandiran V; Reddy AM; Gupta S; Jaisankar P J Biomol Struct Dyn; 2023 Mar; 41(5):2033-2045. PubMed ID: 35043750 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and molecular dynamics simulation studies of quinoline derivatives as protease inhibitors against SARS-CoV-2. Singh VK; Chaurasia H; Kumari P; Som A; Mishra R; Srivastava R; Naaz F; Singh A; Singh RK J Biomol Struct Dyn; 2022; 40(21):10519-10542. PubMed ID: 34253149 [TBL] [Abstract][Full Text] [Related]
8. Identification of doxorubicin as a potential therapeutic against SARS-CoV-2 (COVID-19) protease: a molecular docking and dynamics simulation studies. Sajid Jamal QM; Alharbi AH; Ahmad V J Biomol Struct Dyn; 2022 Oct; 40(17):7960-7974. PubMed ID: 33826483 [TBL] [Abstract][Full Text] [Related]
9. Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an Majumder R; Mandal M J Biomol Struct Dyn; 2022 Feb; 40(2):696-711. PubMed ID: 32897138 [TBL] [Abstract][Full Text] [Related]
10. Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases. Kumar BK; Faheem ; Sekhar KVGC; Ojha R; Prajapati VK; Pai A; Murugesan S J Biomol Struct Dyn; 2022 Feb; 40(3):1363-1386. PubMed ID: 32981461 [TBL] [Abstract][Full Text] [Related]
11. Protein reliability analysis and virtual screening of natural inhibitors for SARS-CoV-2 main protease (M Kapusta K; Kar S; Collins JT; Franklin LM; Kolodziejczyk W; Leszczynski J; Hill GA J Biomol Struct Dyn; 2021 Oct; 39(17):6810-6827. PubMed ID: 32795148 [TBL] [Abstract][Full Text] [Related]
12. In silico discovery of novel inhibitors from Northern African natural products database against main protease (Mpro) of SARS-CoV-2. Byadi S; Oblak D; Kassmi Y; Sadik K; Hachim ME; Podlipnik Č; Aboulmouhajir A J Biomol Struct Dyn; 2023 Apr; 41(7):2900-2910. PubMed ID: 35168469 [TBL] [Abstract][Full Text] [Related]